The Trump administration says a new plan will cut drug prices. It’s not that simple
The proposal takes aim at a controversial drug discount program that is designed to boost revenues for hospitals that serve especially low-income patients.
WASHINGTON — When the Trump administration unveiled a new Medicare proposal this week to cut payments to hospitals as part of a drug reimbursement program, Health and Human Services Secretary Tom Price called the plan a “significant step toward fulfilling President Trump’s promise to address rising drug prices.”
It may not be that simple.
The proposal takes aim at a controversial drug discount program, known as the , which is designed to boost revenues
